These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 26820949)

  • 1. Vita-Assay™ Method of Enrichment and Identification of Circulating Cancer Cells/Circulating Tumor Cells (CTCs).
    Tulley S; Zhao Q; Dong H; Pearl ML; Chen WT
    Methods Mol Biol; 2016; 1406():107-19. PubMed ID: 26820949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
    Friedlander TW; Ngo VT; Dong H; Premasekharan G; Weinberg V; Doty S; Zhao Q; Gilbert EG; Ryan CJ; Chen WT; Paris PL
    Int J Cancer; 2014 May; 134(10):2284-93. PubMed ID: 24166007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.
    Premasekharan G; Gilbert E; Okimoto RA; Hamirani A; Lindquist KJ; Ngo VT; Roy R; Hough J; Edwards M; Paz R; Foye A; Sood R; Copren KA; Gubens M; Small EJ; Bivona TG; Collisson EA; Friedlander TW; Paris PL
    Cancer Lett; 2016 Sep; 380(1):144-52. PubMed ID: 27343980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
    Lu J; Fan T; Zhao Q; Zeng W; Zaslavsky E; Chen JJ; Frohman MA; Golightly MG; Madajewicz S; Chen WT
    Int J Cancer; 2010 Feb; 126(3):669-83. PubMed ID: 19662651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling.
    Magbanua MJ; Park JW
    Methods; 2013 Dec; 64(2):114-8. PubMed ID: 23896286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness.
    Dong H; Tulley S; Zhao Q; Cho L; Chen D; Pearl ML; Chen WT
    Cancer Med; 2019 Jul; 8(8):3864-3874. PubMed ID: 31115187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast isolation and ex vivo culture of circulating tumor cells from the peripheral blood of lung cancer patients.
    Wu WJ; Wang ZH; Wang Z; Deng YL; Shi QH
    Yi Chuan; 2017 Jan; 39(1):66-74. PubMed ID: 28115307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
    Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
    Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.
    Yu L; Sa S; Wang L; Dulmage K; Bhagwat N; Yee SS; Sen M; Pletcher CH; Moore JS; Saksena S; Dixon EP; Carpenter EL
    Cytometry A; 2018 Dec; 93(12):1226-1233. PubMed ID: 30549400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
    Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
    Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.
    Lu Y; Liang H; Yu T; Xie J; Chen S; Dong H; Sinko PJ; Lian S; Xu J; Wang J; Yu S; Shao J; Yuan B; Wang L; Jia L
    Cancer; 2015 Sep; 121(17):3036-45. PubMed ID: 25945459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
    Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
    Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative Enrichment and Isolation of Circulating Tumor Cells for Whole Genome Amplification.
    Kanwar N; Done SJ
    Methods Mol Biol; 2017; 1634():143-152. PubMed ID: 28819847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.
    Xu W; Wu B; Fu L; Chen J; Wang Z; Huang F; Chen J; Zhang M; Zhang Z; Lin J; Lan R; Chen R; Chen W; Chen L; Hong J; Zhang W; Ding Y; Okunieff P; Lin J; Zhang L
    Oncol Rep; 2017 Jun; 37(6):3219-3226. PubMed ID: 28498481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
    Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
    Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.
    Magbanua MJ; Sosa EV; Scott JH; Simko J; Collins C; Pinkel D; Ryan CJ; Park JW
    BMC Cancer; 2012 Feb; 12():78. PubMed ID: 22373240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.